modern
vaccin
base
research
edward
jenner
loui
pasteur
edward
jenner
introduc
cowpox
pustul
fluid
peopl
induc
protect
smallpox
loui
pasteur
attenu
fowl
cholera
pathogen
coincid
pasteur
realiz
pathogen
pathogen
reduc
age
term
attenu
strain
vaccin
latin
vacca
mean
cow
honor
edward
jenner
experi
interestingli
initi
develop
human
vaccin
deepli
relat
anim
vaccin
provid
costeffect
longterm
protect
diseas
stimul
natur
defens
system
host
gener
suffici
immun
new
vaccin
technolog
develop
global
introduc
variou
journal
determin
effici
way
induc
immun
howev
limit
number
develop
adopt
actual
human
vaccin
high
level
safeti
requir
effect
exampl
explain
difficulti
develop
human
vaccin
adjuv
mani
possibl
adjuv
alum
aluminum
compound
common
commerci
adjuv
current
kill
vaccin
variou
new
technolog
adjuv
could
use
safeti
concern
human
use
vaccin
develop
new
technolog
new
adjuv
approv
nation
regulatori
author
author
world
health
organ
guidelin
requir
detail
extens
inform
specif
safeti
avail
vast
clinic
studi
therefor
human
vaccin
develop
expens
time
consum
factor
larg
obstacl
result
reduct
vaccin
research
develop
industri
howev
anim
new
technolog
variou
adjuv
alreadi
use
use
new
type
vaccin
compon
human
use
use
anim
transit
studi
anim
vaccin
trial
obtain
valuabl
inform
could
appli
human
vaccin
develop
newli
emerg
lifethreaten
infecti
diseas
sever
acut
respiratori
syndrom
avian
influenza
ebola
middl
east
respiratori
syndrom
etc
zoonos
transmiss
diseas
caus
contact
type
pathogen
includ
bacteria
virus
parasit
fungi
diseas
current
classifi
zoonos
global
inher
specif
region
world
numer
mode
zoonot
diseas
transmiss
human
infect
insect
mosquito
tick
handl
eat
undercook
raw
meat
come
contact
blood
urin
fece
infect
anim
regard
progress
zoonos
humananim
contact
play
import
role
consid
divers
transmiss
relationship
among
human
anim
sourc
diseas
zoonos
exert
tremend
impact
public
health
therefor
develop
anim
vaccin
critic
function
prevent
human
infect
pathogen
remov
root
caus
infect
anim
new
upcom
agent
could
prevent
effect
anim
vaccin
develop
pathogen
timeous
simultan
frequenc
administr
anim
vaccin
increas
influenc
anim
vaccin
public
health
expand
consid
divers
transmiss
mode
relationship
human
anim
sourc
diseas
need
focu
anim
diseas
vaccin
technolog
public
health
present
paper
two
new
vaccin
technolog
industri
anim
vaccin
introduc
saskatchewan
canada
new
swine
diseas
report
clinic
sign
includ
progress
weight
loss
tachypnea
dyspnea
jaundic
howev
caus
pathogen
initi
unknown
howev
new
viru
nm
size
identifi
similar
featur
porcin
circoviru
identifi
tischer
lyoo
et
al
identifi
report
diseas
first
porcin
circovirusassoci
diseas
pcvad
case
korea
porcin
circoviru
infect
rate
increas
dramat
symptom
becom
sever
sinc
repres
clinic
sign
histolog
characterist
explain
fig
convent
farm
mortal
result
pcvad
rang
affect
korean
swine
industri
sever
porcin
circoviru
type
vaccin
global
vaccin
manufactur
administ
swine
farm
begin
vaccin
farm
swine
mortal
decreas
dramat
despit
vaccin
kill
vaccin
show
effect
diseas
prevent
efficaci
compar
viru
detect
rate
abort
case
good
exampl
vaccin
efficaci
viru
infect
fetu
pregnanc
vaccin
inocul
detect
rate
fetus
howev
detect
rate
fetus
decreas
fig
kill
vaccin
made
possibl
made
viruslik
particl
vlp
vlp
abl
show
similar
immunogen
nativ
viru
sera
induc
vlp
show
strong
reaction
antigen
immunogen
antigen
vlp
vaccin
maintain
nativ
antigen
conform
mimic
whole
structur
wild
viru
lack
viral
nucleic
acid
infecti
vlp
vaccin
categori
subunit
vaccin
produc
use
recombin
protein
technolog
without
viral
replic
system
fig
subunit
vaccin
one
import
disadvantag
express
protein
immunogen
origin
viral
compon
antigen
must
use
level
protect
vlp
vaccin
vlp
similar
structur
origin
viru
elicit
stronger
humor
immun
lower
quantiti
antigen
preexist
kill
subunit
vaccin
furthermor
vlp
contain
genom
materi
safe
vaccin
without
risk
associ
viru
replic
incomplet
inactiv
howev
import
advantag
vlp
vaccin
stimul
b
cell
prolifer
cytotox
tlymphocyt
respons
stimul
b
cell
vlp
strong
enough
elicit
cell
independ
igm
antibodi
induct
structur
vlp
larg
uniqu
microb
mammalian
immun
system
respond
vigor
due
antigen
arrang
antigen
arrang
affect
immun
system
influenc
antigen
epitop
densiti
order
bcell
induct
antibodi
product
assess
show
highli
organ
antigen
respond
promptli
vlp
compris
one
protein
arrang
geometr
dens
repetit
array
induc
strong
immun
respons
addit
induc
strong
bcell
respons
vlp
also
induc
tcell
respons
effici
interact
antigen
present
cell
particularli
dendrit
cell
vlp
process
present
mhc
ii
molecul
activ
thelper
cell
vlp
antigen
stimul
dendrit
cell
induc
rapid
stronger
protect
cytotox
tlymphocyt
respons
class
present
recent
variou
anim
vaccin
develop
vlp
form
foot
mouth
diseas
fmd
viru
serotyp
vlp
vaccin
develop
scientist
india
vlp
vaccin
made
baculoviru
express
system
insect
cell
requir
biosafeti
level
three
barrier
facil
product
follow
year
pirbright
institut
uk
publish
research
regard
new
fmd
vlp
vaccin
neutral
antibodi
titer
greater
log
consid
protect
new
fmd
vlp
vaccin
could
maintain
neutral
antibodi
greater
log
postvaccin
research
result
signific
industri
anim
new
vlp
technolog
make
possibl
manufactur
danger
viru
vaccin
approv
highlevel
barrier
facil
without
infect
risk
therefor
vlp
vaccin
technolog
promis
tool
diseas
prevent
industri
anim
may
porcin
epidem
diarrhea
ped
case
report
unit
state
first
time
ped
acut
contagi
diseas
caus
signific
econom
loss
swine
industri
pregnant
sow
infect
ped
viru
first
day
gestat
decreas
farrow
rate
number
piglet
born
aliv
decreas
pigletslitt
gilt
litter
clinic
sign
histolog
characterist
ped
explain
fig
ped
broken
north
america
unfortun
vaccin
avail
us
anim
medicin
market
one
us
ventur
compani
harri
vaccin
inc
employ
alphaviru
vector
technolog
produc
ped
vaccin
june
new
ped
vaccin
becam
first
ped
viru
vaccin
receiv
condit
us
depart
agricultur
licens
sinc
first
ped
outbreak
fig
alphaviru
vector
technolog
use
cluster
iv
influenza
vaccin
without
adjuv
alphavirus
belong
famili
togavirida
member
alphaviru
possess
singlestrand
rna
nucleocapsid
surround
membran
protein
among
current
recogn
member
venezuelan
equin
enceph
vee
viru
caus
epidem
hors
human
chosen
vaccin
vector
attenu
vee
strain
use
highlevel
heterolog
gene
express
vector
nake
rna
vector
replic
defici
recombin
particl
layer
dna
vector
emerg
ped
vaccin
replic
defici
recombin
particl
use
resembl
vlp
form
variou
viral
structur
protein
includ
influenza
viru
target
vaccin
develop
alphaviru
vector
alphaviru
vector
vaccin
shown
efficaci
protect
challeng
viru
chicken
alphaviru
vector
shown
cellular
humor
respons
protect
lethal
dose
viru
challeng
nonvir
pathogen
like
bacteria
even
cancer
addit
characterist
rna
particl
vaccin
base
alphaviru
vector
explain
tabl
primarili
alphaviru
vector
vaccin
make
possibl
vaccin
emerg
situat
us
ped
case
possibl
produc
ped
vaccin
month
substitut
interest
gene
alphaviru
vector
highli
pathogen
influenza
outbreak
produc
emerg
vaccin
indispens
tradit
vaccin
manufactur
method
like
viru
isol
inactiv
timeconsum
therefor
recombin
vaccin
technolog
like
rna
particl
vaccin
help
tool
prevent
variou
infecti
diseas
histor
earli
version
human
vaccin
technolog
develop
discov
base
anim
exampl
smallpox
fowl
cholera
vaccin
recent
anim
vaccin
market
good
test
market
evalu
new
technolog
adopt
new
technolog
directli
human
actual
case
mani
new
vaccin
technolog
use
anim
vaccin
dramat
chang
recent
anim
vaccin
usag
vlpform
vaccin
rna
particl
vaccin
produc
gene
combin
vector
pathogen
vaccin
made
baculoviru
insect
cell
vee
viru
respect
reduc
time
develop
make
possibl
produc
highli
pathogen
vaccin
antigen
like
fmd
viru
without
highlevel
barrier
facil
import
advantag
vaccin
technolog
allow
us
confront
viral
diseas
like
influenza
viru
hypervari
rel
short
time
base
experi
technolog
anim
effect
prevent
tool
benefici
human
diseas
develop
